Adagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2)

Clinical trial NCT04330664 · COMPLETED

Trial details

NCT number: NCT04330664
Sponsor: Mirati Therapeutics Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer Metastatic Cancer Malignant Neoplastic Disease

Start date: 2020-04-07
Primary completion: 2022-07-29
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.